Response to Letter to the Editor “Intravenous brivaracetam and lorazepam for acute seizure control: Are they equally effective?”

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2020
Source ID
10.1016/j.yebeh.2020.107512

Entities

People

  • Ahmed Sadek
  • Bernhard Greve
  • Brian D. Moseley
  • Jerzy P Szaflarski
  • Julie A. Varner
  • Paulette Williams

Organizations

  • Biogen
  • Eisai
  • GW Pharmaceuticals
  • LivaNova
  • National Institutes of Health
  • National Science Foundation
  • Nonin Medical (United States)
  • Sunovion
  • UCB US
  • United States Department of Defense